Keryx Biopharmaceuticals Inc. (KERX) Stock News, Earnings & History

(NASDAQ:KERX) Healthcare

Enjoy Interactive Tools and Indicators

52wk high: 9.98
52wk low: 1.55
EPS: -0.21
P/E: N/A
Div Rate: N/A
Yield: N/A
Market Cap: 656.71M
Avg Vol (3m): 2.98M

Insider Trading Cheat Sheet

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BENTSUR RON Chief Executive Officer Mar 27 Sale 6.88 31,231 214,869 465,805 Mar 29 05:00 PM
BENTSUR RON Chief Executive Officer Jan 04 Sale 2.74 6,010 16,467 497,036 Jan 04 07:02 PM
Oliviero James F III Chief Financial Officer Jan 04 Sale 2.74 10,859 29,754 589,689 Jan 04 07:01 PM
BENTSUR RON Chief Executive Officer Oct 03 Sale 2.72 746 2,029 478,046 Oct 05 07:02 PM
Oliviero James F III Chief Financial Officer Oct 03 Sale 2.72 4,973 13,527 567,028 Oct 05 07:01 PM
Oliviero James F III Chief Financial Officer Jul 03 Sale 1.99 4,559 9,072 572,001 Jul 06 07:01 PM
BENTSUR RON Chief Executive Officer Jul 03 Sale 1.99 684 1,361 478,792 Jul 06 07:01 PM
BENTSUR RON Chief Executive Officer Apr 18 Buy 1.30 19,100 24,773 479,476 Apr 19 09:15 AM
Yahoo, HV, Market Watch, The Wall St. Journal